Volume Spike: Anadys (ANDS), on ~200% upside analyst call

Posted in pre-market 
May 11th, 2009

Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) is trading higher after ThinkEquity raised the rating to BUY from Accumulate with a $6.00 Target (implied up over 100% and almoist even 200% from Friday’s close).  Shares closed Friday at $2.12 and we are now seeing a $2.4 trade, up 13.68% on 118,060 as of 9:18 AM EST. -JON OGG

Comments are closed

-->